Abstract

Prolactin occasionally is present in serum in a macromolecular complex. The most common form is macroprolactin, an antibody-antigen complex of prolactin (PRL) and immunoglobulin G with a molecular mass of 150–170 kDa (1)(2)(3)(4). The PRL component remains reactive (to various degrees) in immunoassays for PRL (5)(6)(7), and macroprolactin is cleared more slowly than PRL from the circulation, leading to apparent hyperprolactinemia (8). Macroprolactin is bioactive in vitro but has minimal bioactivity in vivo, probably because of the failure of the high-molecular mass complex to cross the capillary membrane to reach target PRL receptors (9). Hyperprolactinemia attributable to macroprolactin may cause diagnostic confusion and lead to inappropriate treatment, and it is important that laboratories characterize the response of their assay to macroprolactin and identify macroprolactin when this is a cause of hyperprolactinemia (1)(5). The Wallac Delfia immunofluorometric PRL assay reacts strongly with macroprolactin, and this response is well characterized (5)(6)(10)(11). High concentrations of polyethylene glycol (PEG) precipitate macroprolactin from serum, and this principle has been used in a screening test for the presence of macroprolactin validated with the Delfia assay (5). We studied the reaction of the PRL assay on …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.